Sera Prognostics, Inc. - Class A Common Stock (SERA)
2.0100
+0.0300 (1.52%)
NASDAQ · Last Trade: Nov 15th, 9:17 AM EST
Sera Prognostics (NASDAQ: SERA) Releases Positive Data from AVERT PRETERM Trial
Sera Prognostics, Inc. (NASDAQ: SERA) is engaged as a health diagnostics company, which is focused around developing treatments and solutions
Via Spotlight Growth · February 15, 2023